இந்தியன் இதயம் இதழ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from இந்தியன் இதயம் இதழ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In இந்தியன் இதயம் இதழ் Today - Breaking & Trending Today

Heart Disease and Sudden Cardiac Arrest: Strategies and Collaborations Needed for Indian American Community


Efforts to raise awareness of heart disease and promote “Healthy Heart” lifestyles are essential.
Heart disease is the number one global public health problem. Indian Americans and South Asians are at a four-times greater risk of heart disease than their western counterparts and have a greater chance of having a heart attack before 50 years of age.
Heart attacks strike South Asian men and women at younger ages, and as a result, both morbidity and mortality are higher among them compared to any other ethnic group. They tend to develop heart disease ten years earlier than other groups.
Almost one in three in this group may die from heart disease before 65 years of age. In India, heart disease remains the number one cause of death. Common risk factors are smoking and a diet high in sugar, salt, refined grains, and fat. ....

United States , University Of Illinois College Medicine , Andhra Pradesh , Srinivas Ramaka , Bellurs Prabhakar , Arunac Ramesh , Vemuris Murthy , Journal Of Indian College Cardiology , Md Srinivasa Heart Center , Community Heart Health , Ramaiah Medical College , Heart Health , Medtronic Foundation , Ui Health , South Asians , South Asian , Mass Index , Indian College , Indian Heart Journal , Illinois College , Terry Vanden Hoek , Srinivasa Heart Center , Heart Disease , Cardiac Arrhythmia , Cardiac Arrest , ஒன்றுபட்டது மாநிலங்களில் ,

Caladrius Biosciences Treats First Patient in the Phase 2b FREEDOM Trial of CLBS16 for the Treatment of Coronary Microvascular Dysfunction


News Category Global Banking & Finance Reviews
Caladrius Biosciences Treats First Patient in the Phase 2b FREEDOM Trial of CLBS16 for the Treatment of Coronary Microvascular Dysfunction
Caladrius Biosciences Treats First Patient in the Phase 2b FREEDOM Trial of CLBS16 for the Treatment of Coronary Microvascular Dysfunction
Initiation of the Phase 2b FREEDOM trial represents the next step in development of CLBS16 as a potential breakthrough treatment for the millions of sufferers of CMD in the U.S., most of whom are women
Patient enrollment underway at The Christ Hospital Health Network in Cincinnati (OH) and Mayo Clinic in Rochester (MN) with additional sites across the United States targeted to open soon ....

United States , Davidj Mazzo , Timothyd Henry , Caladrius Biosciences Inc , American Heart Association , Drug Administration , O Group Christiana Pascale , Exchange Commission , Company Annual Report On Form , Edyth Lindner Center , Corporate Communications , Christ Hospital Health Network , Mayo Clinic , Caladrius Biosciences , Chief Executive Officer , Medical Director , Christ Hospital Health , Indian Heart Journal , Regenerative Medicine Advanced Therapy , Private Securities Litigation Reform Act , Annual Report , Press Release , John Menditto Vice President , Investor Relations , Corporate Communications Phone , Group Christiana Pascale Phone ,